221 related articles for article (PubMed ID: 3917709)
21. Bromocriptine-induced regression of a suprasellar extending prolactinoma during pregnancy.
Bergh T; Nillius SJ; Enoksson P; Wide L
J Endocrinol Invest; 1984 Apr; 7(2):133-6. PubMed ID: 6725868
[TBL] [Abstract][Full Text] [Related]
22. Relationship between the methods of treatment for prolactinomas and the puerperal lactation.
Ikegami H; Aono T; Koizumi K; Koike K; Fukui H; Tanizawa O
Fertil Steril; 1987 May; 47(5):867-9. PubMed ID: 3569564
[No Abstract] [Full Text] [Related]
23. Bromocriptine: Does it jeopardise the result of later surgery for prolactinomas?
Landolt AM; Keller PJ; Froesch ER; Mueller J
Lancet; 1982 Sep; 2(8299):657-8. PubMed ID: 6125789
[No Abstract] [Full Text] [Related]
24. Prolactinomas in women: current therapies.
Robinson AG; Nelson PB
Ann Intern Med; 1983 Jul; 99(1):115-8. PubMed ID: 6344716
[No Abstract] [Full Text] [Related]
25. Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: a case report.
Clayton RN; Webb J; Heath DA; Dunn PJ; Rolfe EB; Hockley AD
Clin Endocrinol (Oxf); 1985 May; 22(5):573-81. PubMed ID: 4028456
[TBL] [Abstract][Full Text] [Related]
26. Effective bromocriptine treatment of a pituitary macroadenoma during pregnancy.
Maeda T; Ushiroyama T; Okuda K; Fujimoto A; Ueki M; Sugimoto O
Obstet Gynecol; 1983 Jan; 61(1):117-21. PubMed ID: 6823341
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of hyperprolactinemic women treated with bromocriptine.
Corenblum B; Taylor PJ
Fertil Steril; 1983 Nov; 40(5):596-9. PubMed ID: 6628704
[TBL] [Abstract][Full Text] [Related]
28. Effects of long-term treatment with bromocriptine on pituitary prolactinoma in a male.
Ayalon D; Eckstein N; Homonnai ZT; Paz GF; Eshel A; Reider I
Int J Gynaecol Obstet; 1982 Dec; 20(6):481-5. PubMed ID: 6130996
[TBL] [Abstract][Full Text] [Related]
29. Effective management of a suprasellar extending prolactinoma during pregnancy.
Pittini L; Minisci N; Negri P
Clin Exp Obstet Gynecol; 1987; 14(3-4):152-4. PubMed ID: 3454722
[TBL] [Abstract][Full Text] [Related]
30. Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas.
Konopka P; Raymond JP; Merceron RE; Seneze J
Am J Obstet Gynecol; 1983 Aug; 146(8):935-8. PubMed ID: 6410917
[TBL] [Abstract][Full Text] [Related]
31. Bromocriptine as prophylactic therapy in prolactinoma during pregnancy.
Canales ES; García IC; Ruíz JE; Zárate A
Fertil Steril; 1981 Oct; 36(4):524-6. PubMed ID: 7286276
[No Abstract] [Full Text] [Related]
32. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
[TBL] [Abstract][Full Text] [Related]
33. Failure of prophylactic surgery to avert massive pituitary expansion in pregnancy.
Belchetz PE; Carty A; Clearkin LG; Davis JC; Jeffreys RV; Rae PG
Clin Endocrinol (Oxf); 1986 Sep; 25(3):325-30. PubMed ID: 3791672
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of the elution pattern of the serum and CSF prolactin fractionated by gel filtration chromatography in cases of bromocriptine-resistant prolactinoma].
Sakamoto T; Kowada M; Hasegawa H; Ishino Y; Mineura K; Wakisaka A; Fukushima M
Neurol Med Chir (Tokyo); 1987 Mar; 27(3):195-201. PubMed ID: 2442642
[No Abstract] [Full Text] [Related]
35. Bromocriptine treatment of prolactin-secreting tumors: surgical implications.
Weiss MH; Wycoff RR; Yadley R; Gott P; Feldon S
Neurosurgery; 1983 Jun; 12(6):640-2. PubMed ID: 6877546
[TBL] [Abstract][Full Text] [Related]
36. To treat or not to treat: hyperprolactinemia.
González ER
JAMA; 1982 Aug; 248(5):515-6. PubMed ID: 7097889
[No Abstract] [Full Text] [Related]
37. Immunohistochemical, electron microscopic, and morphometric studies of human prolactinomas after short-term bromocriptine treatment.
Niwa J; Minase T; Mori M; Hashi K
Surg Neurol; 1987 Nov; 28(5):339-44. PubMed ID: 3660204
[TBL] [Abstract][Full Text] [Related]
38. Ultrastructural localization of prolactin in the human pituitary prolactinomas and its changes by bromocriptine treatment.
Osamura RY; Teramoto A; Watanabe K
Acta Pathol Jpn; 1986 Aug; 36(8):1123-30. PubMed ID: 3776529
[TBL] [Abstract][Full Text] [Related]
39. The long-term effects of megavoltage radiotherapy as sole or combined therapy for large prolactinomas: studies with high definition computerized tomography.
Johnston DG; Hall K; Kendall-Taylor P; Ross WM; Crombie AL; Cook DB; Watson MJ
Clin Endocrinol (Oxf); 1986 Jun; 24(6):675-85. PubMed ID: 3098457
[TBL] [Abstract][Full Text] [Related]
40. Dopamine agonists and pituitary tumor shrinkage.
Bevan JS; Webster J; Burke CW; Scanlon MF
Endocr Rev; 1992 May; 13(2):220-40. PubMed ID: 1352243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
